RWM
ABMD

Raffa Wealth Management’s Abiomed Inc ABMD Stock Holding History

Raffa Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed -$1.3K – 774
2019
Q2 		$1.3K Buy
+5
New +$1.33K ﹤0.01% 675

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Raffa Wealth Management's ABMD Position: Q3 2019 in Review

Raffa Wealth Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 5 shares — an estimated $1.3K sold.

Raffa Wealth Management first reported a position in ABMD in Q2 2019 and held it in 1 quarter. The position peaked at $1.3K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Raffa Wealth Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Raffa Wealth Management sold 5 Abiomed Inc shares in Q3 2019, an estimated $1.3K.
  • Raffa Wealth Management first reported a position in Abiomed Inc in Q2 2019 and held it in 1 quarter.
  • Raffa Wealth Management's Abiomed Inc position peaked at $1.3K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Raffa Wealth Management's 13F filing for Q3 2019, filed 27 Jul 2026.